MedTrace Logo

Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

NCT05101031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-11-21

No results posted yet for this study

Summary

The objective of the study is to observe the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during rapid fluid bolus.

Conditions

  • Undifferentated Shock

Interventions

DEVICE

Starling SV

The Starling SV will monitor the change in hemodynamic variables (i.e. CO, SV, HR, SV) as assessed during the initial fluid resuscitation in individuals with hypotension related to infection.

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Ivor Douglas

    lead OTHER

Principal Investigators

  • Ivor Douglas, MD · Denver Health Medical Center

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2022-12-17
Completion
2022-12-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05101031 on ClinicalTrials.gov